Before accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.
Last Price: 232.58 - Change: 3.13 - Change %: 1.3641
Industry: Medical Instruments & SuppliesFollow @stockchartsai on Twitter
In the past 30 trading days, TFX has been trading in a range between $219.95 and $179.09 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.
TFX is trading between resistance at $245.19 about 5% to the upside and support at $227.77 -2% to the downside. If it can break above the resistance, it could have some more upside to the next line of resistance at $274.11, about a 18% move. If the price starts to turn down and fails to get through this level or enters a yellow zone, we would consider profit taking or exiting the position. If it enters a red zone on the chart we would exit the position.
Teleflex Incorporated (TFX) entered a Green zone 25 days ago on the AI powered stock chart. Wall Street analysts have a recent rating of 3.500, which is a Buy. The current analyst target price is $252.25, which gives it a potential upside of 8.46 % from the recent price of 232.58. The stock is trading 18.13% (potential upside) below its 52 week high of $274.74 and 31.15 % (potential downside) above its 52 week low of $177.34 - based on the recent price.
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices.
|Glancy Prongay & Murray LLP Announces Investigation of Teleflex Incorporated (TFX)
NEW YORK--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Teleflex Incorporated (NYSE: TFX) concerning the Company and its directors' and officers' possible violations of state laws. If you own Teleflex stock, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Tom Kennedy, of GPM, 230 Park Avenue, Suite 358, New York, NY 10169 at tkennedy.
Source: Business Wire
Wed, 06 Dec 2023 09:36:00 -0500
|Teleflex (TFX) Signs Peripheral Access Purchasing Deal With PINC
Teleflex (TFX) secures the Peripheral Access purchasing agreement with Premier, Inc.
Source: Zacks Investment Research
Wed, 06 Dec 2023 09:01:18 -0500
|Teleflex Awarded Peripheral Access Agreement with Premier, Inc.
WAYNE, Pa., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it was awarded the Peripheral Access purchasing agreement with Premier, Inc. Effective December 1st, 2023, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Teleflex's Peripheral Access products. Premier has awarded Teleflex a national multi-source agreement for Peripherally Inserted Central Catheters (PICCs), PICC navigation equipment, and Midlines.
Tue, 05 Dec 2023 06:30:00 -0500
|Should You Pick Teleflex Stock After 20% Gains This Month?
Teleflex stock (NYSE: TFX), which provides instruments and consumables for laboratories, trades at $220 per share, 50% below the level seen in March 2021.
Mon, 04 Dec 2023 08:00:00 -0500
|December Looks Great For Investors Who Own 9 Stocks
Investors can only hope stocks do as well in December as they did in November. There are definitely some S&P 500 stocks that glisten.
Source: Investors Business Daily
Fri, 01 Dec 2023 08:00:11 -0500
Stock Analyzed Each Night
Easily Upload Track Your Stocks
See Lists of Stocks Starting New Trends
The information contained on this website is solely for educational purposes, and does not constitute investment advice. The risk of trading in securities markets can be substantial. By accessing this site, you agree we are not liable, whether in contract, tort (including negligence) or otherwise, in respect of any damage, expense or other loss you may suffer arising out of such information or any reliance you may place upon such information from this site. Stocks, Futures and options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stock, futures and options markets. Don't trade with money you can't afford to lose. This website is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this website. The past performance of any trading system or methodology is not necessarily indicative of future results. Individual results may vary, and testimonials are not claimed to represent typical results. All testimonials are by real people, and may not reflect the typical purchaser’s experience, and are not intended to represent or guarantee that anyone will achieve the same or similar results. HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY, SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.